Skip to main content

Share story

Infrastructure

Tower Semiconductor teams with NVIDIA on 1.6T silicon photonics for AI data centers

Tower Semiconductor Teams with NVIDIA to Advance AI Infrastructure with 1.6T Data Center Optical Modules Image: Primary
Tower Semiconductor announced a collaboration with NVIDIA on silicon photonics for 1.6T data center optical modules. The modules support AI infrastructure and use Tower's advanced platform. They are designed for NVIDIA networking protocols. Tower's silicon photonics enables up to double the data rate of prior solutions. This increases bandwidth and throughput for optical connectivity. The technology speeds AI application performance. Russell Ellwanger, CEO of Tower Semiconductor, said the company is proud to deliver advanced high-speed technologies that support demanding data center and AI requirements. He said Tower continues to invest significantly across its SiGe and silicon photonics platforms. Gilad Shainer, senior vice president of networking at NVIDIA, said the exponential growth of AI is driving the need for a new class of high-speed scalable networking to connect AI infrastructure. He said NVIDIA is collaborating with Tower Semiconductor to advance the ecosystem.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Tower Semiconductor and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.